Gujarat Themis Biosyn Ltd shares jump 1.13% as disclosure under SEBI regulations received for Sachin D Patel
Why did Gujarat Themis Biosyn Ltd shares jump today?
Shares of Gujarat Themis Biosyn Ltd saw a positive movement today, trading at ₹360.95 with a gain of 1.13% as of 09:21 AM on Friday. The upward trend in the stock price appears to be driven by a recent corporate disclosure made to the stock exchanges.
The key news is related to a filing under the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. Specifically, an individual named Sachin D. Patel submitted a disclosure to both the BSE and NSE regarding an acquisition of shares in the company. This formal intimation under Regulation 10(6) is a required step after a substantial acquisition is made, ensuring transparency in the market. The letter mentions that a prior intimation for an "Inter Se Transfer" (a transfer between related parties) had already been made on July 14, 2026, and this filing completes the regulatory process.
Such disclosures about significant share acquisitions by individuals or entities are often closely watched by investors. They can signal confidence in the company's prospects from someone with inside knowledge, potentially leading to increased buying interest and contributing to a rise in the share price. In this case, the formalization of the acquisition by Sachin D. Patel has likely provided a positive sentiment boost to Gujarat Themis Biosyn Ltd shares.
What does Gujarat Themis Biosyn Ltd do?
Gujarat Themis Biosyn Ltd is a publicly listed company with its shares traded on major Indian stock exchanges, including BSE Limited and the National Stock Exchange of India Limited, under the symbol GUJTHEM and scrip code 506879. The company's registered administrative address is located in Vile Parle (West), Mumbai, Maharashtra.
Its business activities involve compliance with corporate and securities regulations, specifically those related to the acquisition of shares. The company engages in the process of making formal disclosures to regulatory authorities and stock exchanges in the event of a substantial acquisition of its shares, as governed by the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Gujarat Themis Biosyn Ltd Financials
In CroresGujarat Themis Biosyn Ltd reported a revenue increase from ₹43.37 crore in December 2025 to ₹44.23 crore in March 2026, indicating modest top-line growth. However, the company's profit declined over the same period, falling from ₹12.46 crore to ₹10.89 crore. This presents a mixed trend where rising revenue did not translate into higher profitability.
Gujarat Themis Biosyn Ltd Shareholding Pattern
Promoter holding stands at 70.87% of the total share capital. Foreign Institutional Investors (FIIs) hold 1.76% stake in the company, while Domestic Institutional Investors (DIIs) hold 1.17%. Public shareholders hold the remaining 26.18% stake in Gujarat Themis Biosyn Ltd.
Gujarat Themis Biosyn Ltd FAQs
Q: Why did Gujarat shares jump 1.13% today?
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachin D Patel. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Gujarat Themis Biosyn Ltd?
As per the latest data, promoters hold 70.87% stake in Gujarat Themis Biosyn Ltd, while FII holding stands at 1.76%. Domestic institutional investors hold 1.17%, and public shareholders account for 26.18% of the equity.
Q: What is the current stock price of Gujarat Themis Biosyn Ltd?
Gujarat Themis Biosyn Ltd shares are currently trading at ₹360.95, recording a gain of 1.13% from the previous close.
Q: What is the market capitalization of Gujarat Themis Biosyn Ltd?
The company currently has a market capitalization of ₹3933.1 crore, reflecting its valuation in the Indian equity market.